MIA News Archives

In an interview with MIA, Dr. Horowitz discusses his recent article on why tapering off antidepressants can take months or even years.

New research finds the negative drug effects most commonly associated with initiating antidepressant discontinuation are anxiety, suicidal thoughts, vomiting, and rashes.

New research by Jim van Os and Peter Groot finds that using hyperbolic tapering to discontinue antidepressants reduces withdrawal effects.

New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.

New research finds that the non-physical aspects of withdrawal from SSRIs are often overlooked.

Mark Horowitz and David Taylor provide advice on how to tell the difference between antidepressant withdrawal and depression relapse.

A new article in Lancet Psychiatry finds that slower tapering of SSRIs is better for preventing antidepressant withdrawal effects.

MIA's Richard Sears interviews psychotherapist Anne Guy about working with clients withdrawing from psychiatric drugs.

Researchers suggest that antidepressant withdrawal can be a possible precipitant of suicide.

Growing rates of long-term psychiatric drug prescriptions and documented issues with withdrawal demonstrate a need for safe deprescribing practices.

Study reveals schizophrenia patients find little support from mental health staff in reducing side effects-heavy drugs.

Patient advocates join with researchers and service users to present first-hand experiences of antidepressant withdrawal.

A new update to the NICE guideline for depression suggests providers discuss long-term, severe antidepressant withdrawal symptoms.

Long-term treatment with antipsychotic drugs is currently considered the standard treatment for patients diagnosed with ‘schizophrenia.’ A new study challenges this practice, however. The...

Psychiatrists argue that current practice fails to account for the interaction of biological, psychosocial and iatrogenic factors.

Researchers interviewed people who were given medical advice to discontinue antidepressants.

Study finds that 74% of patients with a psychotic disorder off antipsychotics at end of 10 years are in remission.

Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.

Antidepressant users share their frustrations towards a healthcare system that overprescribes but is ill-equipped to support with discontinuation and withdrawal symptoms.

In the first systematic review of withdrawal problems that patients experience when trying to get off SSRI antidepressant medications, researchers found that withdrawing from SSRIs was comparable to trying to quit addictive benzodiazepines.

New guidance for primary care doctors in the UK on antidepressant discontinuation acknowledges severe and long-lasting withdrawal symptoms.

Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.

A review of clinical practice guidelines for antidepressant discontinuation from across the English-speaking world reveals major pitfalls.

A researcher and service user Stevie Lewis recounts her own experience with antidepressant withdrawal and what she wishes her doctors knew.

Common second-generation antipsychotic medications are causing symptoms of obsessive-compulsive disorder to emerge in many people who previously only had schizophrenia symptoms, according to a...